Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter Prospective Real-world Study on Bisphosphonates Targeting Triple-negative Breast Cancer

NCT04045522 is registered in ClinicalTrials.gov with Shengjing Hospital as lead sponsor.

NCT NCT04045522
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04045522 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter Prospective Real-world Study on Bisphosphonates Targeting Triple-negative Breast Cancer
Lead sponsor
Shengjing Hospital
Phase
Observational
Overall status
Unknown status
Start date
September 1, 2019
Completion date
August 31, 2022
Enrollment
120 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer